Franck Grimaud

Directeur/Membre du Conseil chez IOMAI CORPORATION

59 ans

Health Technology

Commercial Services

Consumer Services

Profil

Franck Charles Marie Grimaud is the founder of Vivalis SA, founded in 1999, where the title held was President, CEO & Head-Investor Relations from 2010 to 2013.
Current jobs include Director & Deputy Chief Executive Officer at Valneva Usa, Inc. (United States) since 2015; Chief Executive Officer & Director at Atlantic Biotherapies since 2015; Chairman-Governing Board at Pays de la Loire Participations since 2016; Chairman at Syndicat Mixte Atlanpole since 2018; Chairman-Governing Board at Fonds Pays De La Loire Participations since 2016; Director at Valneva Scotland Ltd. since 2017; Co-Managing Director at VALNEVA Austria GmbH since 2013; Director & Managing Director at Vaccines Holdings Sweden AB since 2014; Director at BliNK Biomedical SAS; Director at Valneva Sweden AB since 2015; Director at Valneva UK Ltd. since 2015; Director & President at Valneva Canada, Inc. since 2015; and Chief Business Officer at Intercell Austria AG since 2013.
Former jobs include Chairman at Vivalis Toyama Japan KK from 2013 to 2018; Director at France Biotech Association; President & Managing Director at Smol Therapeutics SAS; Director at Grimaud Deyang Animal Co. Ltd. from 2000 to 2019; Director at Chengdu Grimaud Breeding Co. Ltd. from 2000 to 2018; and Co-President & Chief Business Officer at Valneva SE from 2013 to 2025.
Education includes an MBA from the University of Ottawa.

Postes actifs de Franck Grimaud

Sociétés	Poste	Début
IOMAI CORPORATION	Directeur/Membre du Conseil	01/12/2015
Valneva Scotland Ltd. Valneva Scotland Ltd. BiotechnologyHealth Technology Engages in producing encephalitis vaccine	Directeur/Membre du Conseil	01/06/2017
Atlanpole Biotherapies Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Provides immunotherapy, regenerative medicine and radio pharmacy bio cluster services	Président	01/02/2018
BliNK Biomedical SAS BliNK Biomedical SAS BiotechnologyHealth Technology Develops antibody-based therapeutics	Directeur/Membre du Conseil	-
Pays de la Loire Participations Pays de la Loire Participations Investment ManagersFinance Acts as Private Equity Fund	Directeur/Membre du Conseil	01/09/2016
Intercell Austria AG	Corporate Officer/Principal	01/01/2013
Valneva Canada, Inc. Valneva Canada, Inc. Medical DistributorsDistribution Services Engages in marketing and distribution of vaccines	President	01/01/2015
Valneva Sweden AB Valneva Sweden AB BiotechnologyHealth Technology Manufactures vaccines and medicinal drugs	Directeur/Membre du Conseil	01/02/2015
Valneva UK Ltd. Valneva UK Ltd. Medical/Nursing ServicesHealth Services Provides health care services	Directeur/Membre du Conseil	19/10/2015
░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░

Tous les postes actifs de Franck Grimaud

Anciens postes connus de Franck Grimaud

Sociétés	Poste	Fin
░░░░░░░ ░░	░░░░░░░░░	-
░░░░░░░ ░░░░░░ ░░░░░░ ░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░░ ░░	░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░

Voir l'expérience en détail de Franck Grimaud

Formation de Franck Grimaud

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Franck Grimaud

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	20
Vivalis SA Vivalis SA Pharmaceuticals: OtherHealth Technology Manufactures human and animal vaccines	Health Technology
University of Ottawa University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Intercell USA, Inc. Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants	Health Technology
France Biotech Association France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry	Commercial Services
Valneva Scotland Ltd. Valneva Scotland Ltd. BiotechnologyHealth Technology Engages in producing encephalitis vaccine	Health Technology
Atlantic Biotherapies
Pays de la Loire Participations Pays de la Loire Participations Investment ManagersFinance Acts as Private Equity Fund	Finance
Valneva SE Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases	Health Technology
Atlanpole Biotherapies Atlanpole Biotherapies Miscellaneous Commercial ServicesCommercial Services Provides immunotherapy, regenerative medicine and radio pharmacy bio cluster services	Commercial Services
Smol Therapeutics SAS
Vivalis Toyama Japan KK
Grimaud Deyang Animal Co. Ltd.
Chengdu Grimaud Breeding Co. Ltd.
Valneva Austria GmbH Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops and commercializes vaccines for infectious diseases	Commercial Services
Vaccines Holdings Sweden AB Vaccines Holdings Sweden AB BiotechnologyHealth Technology Develops and distributes vaccines and biological products	Health Technology
BliNK Biomedical SAS BliNK Biomedical SAS BiotechnologyHealth Technology Develops antibody-based therapeutics	Health Technology
Valneva Sweden AB Valneva Sweden AB BiotechnologyHealth Technology Manufactures vaccines and medicinal drugs	Health Technology
Intercell Austria AG
Valneva UK Ltd. Valneva UK Ltd. Medical/Nursing ServicesHealth Services Provides health care services	Health Services
Valneva Canada, Inc. Valneva Canada, Inc. Medical DistributorsDistribution Services Engages in marketing and distribution of vaccines	Distribution Services